Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:14 PM
Ignite Modification Date:
2025-12-24 @ 12:14 PM
NCT ID:
NCT00612261
Eligibility Criteria:
Inclusion Criteria:
* recent onset (within the 6 months prior to enrollment) of macular edema resulting from BRVO
* best corrected Early Treatment Diabetic Retinopathy Study (ETDRS) scores ≤ 40 letters (Snellen equivalent ≤ 20/40
* intraretinal hemorrhages involving the foveal centers
* generalized breakdown of the inner blood-retina barrier, as documented by diffuse fluorescein leakage on angiography, or diffuse thickening of the retina on optical coherence tomography (OCT), with involvement of the foveal center and most of the macular area, and with foveal thicknesses ≥ 250 micrometer
Exclusion Criteria:
* prior history of intraocular surgery including cataract extraction
* prior history of laser treatments including panretinal photocoagulation and focal/grid macular photocoagulation
* prior history of elevated intraocular pressure secondary to steroid treatment
* prior history of glaucoma or ocular hypertension
* presence of comorbid ocular conditions that might affect visual acuity (VA).
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00612261
Study Brief:
Protocol Section:
NCT00612261